Charles Schwab Investment Management Inc Adverum Biotechnologies, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.68 - $1.59 $18,020 - $42,136	-26,501 Reduced 42.12%	36,413 $57,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $60,397 - $609,007	62,914 New	62,914 $60,000
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.34 $158,666 - $262,485	-195,885 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $24,912 - $39,495	-20,254 Reduced 9.37%	195,885 $257,000
Q3 2021 Nov 16, 2021	SELL	$2.08 - $3.6 $833,609 - $1.44 Million	-400,774 Reduced 64.96%	216,139 $470,000
Q2 2021 Aug 16, 2021	BUY	$3.36 - $10.56 $19,504 - $61,300	5,805 Added 0.95%	616,913 $2.16 Million
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $164,920 - $255,751	17,810 Added 3.0%	611,108 $6.03 Million
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $202,861 - $293,984	20,616 Added 3.6%	593,298 $6.43 Million
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $1.24 Million - $2.6 Million	120,286 Added 26.59%	572,682 $5.9 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $573,557 - $1.72 Million	67,240 Added 17.46%	452,396 $9.45 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $445,132 - $910,345	55,781 Added 16.94%	385,156 $3.76 Million
Q4 2019 Feb 07, 2020	BUY	$5.12 - $12.22 $39,813 - $95,022	7,776 Added 2.42%	329,375 $3.8 Million
Q3 2019 Nov 08, 2019	BUY	$5.24 - $15.89 $1 Million - $3.05 Million	191,657 Added 147.49%	321,599 $1.75 Million
Q2 2019 Aug 09, 2019	BUY	$5.1 - $11.89 $19,431 - $45,300	3,810 Added 3.02%	129,942 $1.55 Million
Q1 2019 May 14, 2019	BUY	$3.03 - $6.02 $37,738 - $74,979	12,455 Added 10.96%	126,132 $661,000
Q2 2018 Aug 08, 2018	BUY	$5.3 - $6.9 $602,488 - $784,371	113,677 New	113,677 $603,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account